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Abstract 
Cigarette smoke exposure is a strong risk factor for cerebral vascular disease such as stroke. How-
ever, the underlying molecular mechanisms to explain how cigarette smoke exposure leads to cere-
bral vascular disease are poorly understood. The present study was designed to examine the hy-
pothesis that upregulation of endothelin ETB2 receptors that locate in cerebral vascular smooth 
muscle cells might be the molecular mechanism that mediates the cigarette smoke-associated in-
crease in risk for cerebral vascular disease. Furthermore, the mechanisms of the mitogen activated 
protein kinase (MAPK)-mediated upregulation of endothelin receptors involved in this process were 
explored.  
Rat cerebral arteries were incubated in serum free medium for 24 h in the presence of lipid-soluble 
cigarette smoking particles with or without specific inhibitors: MEK specific U0126, p38 specific 
*Manuscript Text
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SB202190, JNK specific SP600125, NF-κβ specific antagonists BMS- or IMD-0354, transcription 
inhibitor actinomycin D, or translation blocker cycloheximide. Contractile responses to the endo-
thelin ETB receptor agonist sarafotoxin 6c were investigated by a sensitive myograph. The expres-
sion of the endothelin ETB2 receptors were verified by measurement of mRNA with quantitative 
real time PCR and protein using immunohistochemistry. 
Organ culture per se induced transcriptional upregulation of endothelin ETB2 receptors in vascular 
smooth muscle cells. This upregulation was further increased at the transcriptional level by addition 
of lipid-soluble cigarette smoking particles, but not by nicotine or water-soluble cigarette smoke 
particles. The additional enhanced upregulation of endothelin ETB receptors by lipid-soluble ciga-
rette smoking particles was inhibited by U0126, SP600125, actinomycin D, and cycloheximide, 
suggesting that the underlying molecular mechanisms involved in this process include activation of 
MAPK MEK and JNK, via transcriptional and translational mechanisms. Understanding how ciga-
rette smoke increases the risk for cerebral vascular disease like stroke may provide new strategies 
for the treatment. 
  
Keywords: Organ culture; Cerebral arteries; Vascular smooth muscle cells, Lipid-soluble cigarette 
smoking particles, Endothelin ETB receptor, MAPK.  
 
1 Introduction 
 Cerebral vascular disease is one of the leading causes of death (Strong et al., 2007) and  disability 
in the developed countries (Rosamond et al., 2008). Most of the clinical cases are of ischemic origin 
(Zia et al., 2007). Major risk factors for stroke include hypertension, elevated blood levels of low-
density lipoprotein, and exposure to cigarette smoke (Braunwald, 1997). All three risk factors mod-
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ify the progression of local vascular inflammation and atherosclerosis, and associate with elevated 
production of endothelin-1 from the endothelial cells (Zeiher et al., 1995;Ihling et al., 1996) as well 
as increase in the expression of G-protein coupled receptors of the endothelin ETA and ETB recep-
tors (Winkles et al., 1993). These data suggest that endothelin system plays an important role in 
pathogenesis of cerebral vascular disease.  
 
Endothelin ETA receptors are located to the smooth muscle cells and mediate vasoconstriction. 
Vascular endothelin ETB receptors are divided into two subtypes: endothelin ETB1 and ETB2 re-
ceptors. The endothelin ETB1 receptors are expressed in the endothelial cells and mediate vasodila-
tion through the release of nitric oxide and prostacyclin, while endothelin ETB2 receptors that are 
located to the smooth muscle cells mediate vasoconstriction (Arai et al., 1990;Batra et al., 1993;de 
Nucci et al., 1988;Kedzierski et al., 2001;Sakurai et al., 1990). The two endothelin ETB receptor 
subtypes only represents a single molecular genotype, differing only in function and location (Giller 
et al., 1997).  
 
Studies demonstrate that contractile endothelin ETB2 receptors are inducible and expressed via 
transcriptional mechanisms in the smooth muscle cells after experimental cerebral ischemia 
(Stenman et al., 2002), in atherosclerotic lesions (Dagassan et al., 1996;Iwasa et al., 1999), in con-
gestive heart failure (Cannan et al., 1996), in subarachnoid haemorrhage (Roux et al., 
1995;Hansen-Schwartz et al., 2003), or during organ culture of arteries (Adner et al., 1998;Moller 
et al., 1998). The function of induced endothelin ETB2 receptors include abnormal vessel contrac-
tion and/or vasospasm, which may contribute to cerebral ischemia (Zuccarello et al., 1994). 
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In order to explore how endothelin ETB2 receptors are induced and expressed, we have developed 
an organ culture model and demonstrated that organ culture of isolated cerebral arteries is a useful 
model for mimicking the G-protein coupled receptor alteration seen in cerebrovascular ischemia in 
vivo (Hoel et al., 2001;Rosamond et al., 2008;Hansen-Schwartz et al., 2002;Henriksson et al., 
2003). The organ culture model allows in-depth study of the underlying intracellular mechanisms 
that are responsible for alteration in expression of the G-protein coupled receptors in cerebral arter-
ies.  
 
The present study was designed to test the hypothesis that cigarette smoke particles may activate 
mitogen-activated protein kinase pathways and subsequently results in upregulation of the endo-
thelin ETB2 receptors via transcriptional mechanisms. This was achieved by studying lipid-soluble 
smoke particle-induced alteration of endothelin ETB2 receptors at function, mRNA, and protein 
levels in presence and absence of specific inhibitors for MEK1/2, p38, JNK, NF-κβ, transcription, 
and translation. The results show that lipid-soluble cigarette smoking particles, but not water-
soluble cigarette smoke particles or nicotine, induce upregulation of ETB2 receptors in cerebral 
arteries. The underlying molecular mechanisms involve activation of MAPK-mediated transcrip-
tional mechanisms.  
 
2 Materials and Methods  
2.1 Reagents 
Reference research cigarettes were obtained from the University of Kentucky, USA. Dulbecco’s 
modified Eagle’s medium (DMEM: 1 mg/ml glucose, 4 mM L-glutamine, 0.11 mg/ml sodium py-
ruvate), antibiotics mix (10,000 units/ml penicillin, 10,000 µg/ml streptomycin, and 25 µg/ml am-
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photericin), and Trizol were from Invitrogen, USA. 1-bromo-3-chloropropane, dimethyl sulfoxide 
(DMSO), absolute ethanol, nicotine, U0126, SB202190, SP600125, IMD-0354, actinomycin D, 
cycloheximide, 5-hydroxytryptamine, carbachol, and other high grade chemicals were purchased 
from Sigma-Aldrich, USA. In addition we used BMS-345541 (Merck, Germany), Sarafotoxin 6c 
(PolyPeptide Group, France), and RNase free water (Qiagen, USA).  
 
2.2 Extraction of DMSO lipid soluble cigarette Smoking Particles (DSP) 
Three cigarettes (0.8 mg nicotine per cigarette, reference research cigarettes, University of Ken-
tucky, USA) were smoked by the aid of vacuum through a sterile cotton filter and dissolved in 1 ml 
DMSO or distilled water. Detailed description of the extraction and measurement of the nicotine 
concentration has been described before (Zhang et al., 2006). Preliminary tests have revealed that 
water-soluble cigarette smoke particles or nicotine (25 ng/ml, dose found in plasma of smokers) 
have no effect on the G-protein coupled receptor alteration; therefore, we only focus henceforth on 
the DSP effect. The concentration of DSP used in the present study (0.15 µl DSP pr. ml DMEM) is 
equivalent to the plasma level of approximately 25 ng/ml nicotine found in smokers (Benowitz et 
al., 1994;Foulds et al., 2003). 
 
2.3 Isolation of the cerebral arteries and organ culture  
Studies were approved by the Danish Animal Experiments Committee guidance (no. 2006/561-
1139). Male Sprague-Dawley rats (n = 136; 300-350 g) (Taconic, Denmark) were anaesthetized 
with CO2 and decapitated. The brains were removed and immediately chilled in ice-cold bicarbon-
ate buffer solution (for composition see below). The right and left middle cerebral arteries were 
isolated and dissected free of adhering tissue. 
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Middle cerebral artery segments (2.0– 3.0 mm long), free from surrounding cerebral tissue with 
intact endothelium, were studied immediately (fresh, 0 h organ culture) or incubated for 24 h at 37 
°C in humidified 5 % CO2 and 95 % air in 1 ml serum free DMEM supplemented with an antibiot-
ics mix (10,000 units/ml penicillin, 10,000 µg/ml streptomycin, and 25 µg/ml amphotericin).  
 
The concentrations of the inhibitors were adjusted so that maximum inhibition without toxic effect 
was achieved. The concentrations tested were: U0126 = 10-7 M, 10-6 M, and 10-5 M (10-5 M 
U0126 chosen); SB202190 = 10-7 M, 10-6 M, and 10-5.5 M; SP600125 = 10-7 M and 10-6 M (10-
6
 M SP600125 chosen); BMS-345541 = 10-8 M, 10-7 M, 10-6.5 M, 10-6 M, and 10-5.5 M; IMD-
0354 = 10-8 M, 10-7 M, 10-6.5 M, 10-6 M, and 10-5.5 M; actinomycin D = 10-9 M, 10-8 M, 10-7 
M, and 10-6 M (10-8 M actinomycin D chosen); cycloheximide = 10-8 M, 10-7.5 M, 10-7 M, and 
10-6 M (10-7 M cycloheximide chosen).  
 
DMSO, DSP, inhibitors, or DSP along with inhibitors were added to the DMEM medium at the 
initiation of the incubation. The final volume of DMSO added to the 1 ml DMEM was always kept 
at 2.5 µl. This DMSO dose did not modify the upregulation of receptors. 
 
Fresh or organ cultured cerebral artery ring segments were either mounted in myographs for in vitro 
pharmacology or snap-frozen with dry ice and kept at -80 °C for real time PCR or immunohisto-
chemistry. 
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2.4 In vitro pharmacology 
A sensitive myograph was used for recording of the isometric tension in isolated cerebral vessel 
segments (Hogestatt et al., 1983;Mulvany et al., 1977). The vessel segments were threaded on two 
40 µm-diameter stainless steel wires and mounted on a Mulvany-Halpern myograph (Danish Myo 
Technology A/S, Denmark). One of the wires was connected to a force displacement transducer 
attached to an analog-digital converter unit (PowerLab from ADInstruments, New Zealand), while 
the other wire was attached to a movable displacement device allowing fine adjustments of vascular 
tension by varying the distance between the two wires. The measurements were recorded on a com-
puter using the software Chart 5.4.2 (ADInstruments, U.K.).  
 
The segments were immersed into a temperature-controlled (37 °C) buffer solution (composition in 
mM/ml; NaCl = 119, NaHCO3 = 15, KCl = 4.6, MgCl2 = 1.2, NaH2PO4 = 1.2, CaCl2 = 1.5, and 
glucose = 5.5). The buffer was continuously gassed with 5 % CO2 in O2 resulting in a physiologi-
cal pH at 7.4. The vessels were given an initial pre-tension of 2 mN/mm and were adjusted to this 
tension for 1 hour. Contractile capacity was determined by exposure to potassium rich (60 mM K+) 
buffer solution with the same composition as the bicarbonate buffer solution except that NaCl was 
exchanged for KCl. The threshold for minimum 60 mM K+-contraction response was set to 0.7 mN 
(if the K+-contraction was lower, the data from the vessel was discarded).  
 
The carbachol resulted in dilatation after 5-hydroxytryptamine mediated contraction was used as 
measurement of endothelium functionality. Carbachol mediates an endothelium dependent dilation 
of vessels via release of nitric oxide. Middle cerebral artery segments were pre-contracted with 300 
nM 5-hydroxytryptamine and subsequently exposed to 10 µM carbachol. A strong dilation by car-
bachol indicated intact functional endothelium, whereas a weak or absent dilation indicates dam-
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aged or unfunctional endothelium (i.e. due to mechanical damage of the endothelium during mount-
ing on wires). Threshold for intact endothelium function was set at to 30 % carbachol induced dila-
tation, and only vessels showing this response or more were included in the study. Concentration-
response curves were subsequently obtained by cumulative application of the agonist: endothelin 
ETB receptor specific agonist sarafotoxin 6c (10-14 M to 10-7 M). Specificity of detailed receptor 
charactering has been performed before (Henriksson et al., 2003;Sandhu et al., 2010). 
 
2.5 Molecular Biology  
The middle cerebral artery vessel segments were after removal snap-frozen with dry ice in green-
cap tubes containing Lysing Matrix D provided in the FastRNA Pro Green Kit (Q Biogene, USA). 
Total cellular RNA was extracted with the use of the FastRNA Pro Green Kit. The vessels were 
homogenized in 1 ml of Trizol Solution by using a FastPrep FP120 instrument (Q Biogene, USA). 
The samples were centrifuged for 15 min at 4 °C at 12,500 g, and the liquid phase was transferred 
to 300 µl of 1-bromo-3-chloropropane. After centrifugation for 15 min at 4 °C at 12,500 g the upper 
phase was transferred to 500 µl of 100 % isopropanol and stored at -20 °C overnight. Next day the 
samples were centrifuged for 20 min at 4 °C at 15,000 g. The supernatant was removed. The pellet 
was washed with 500 µl 75 % ethanol, air dried and redissolved with RNase free water. Total RNA 
amount and purity was determined using NanoDrop 2000c (Thermo Science, USA).  
 
Reverse transcription of total RNA to cDNA was performed with the TaqMan Reverse Transcrip-
tion Reagents (Applied Biosystems, USA) in a GeneAmp PCR System 2400 (Perkin-Elmer, USA). 
First-strand cDNA was synthesized from 250 ng total RNA in a 20 µl reaction volume with random 
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hexamers used as primers. The PCR reaction was performed with the following setup: 42 °C for 90 
min followed by 72 °C for 10 min. The cDNA was diluted with 30 µl of RNase free. 
 
Real time PCR was performed in a 7500 Fast Real Time PCR sequence detection system (Applied 
Biosystems, USA) with the SYBR Green PCR Master Mix (Applied Biosystems, USA) with 1 µl 
cDNA synthesized above as template in a 25-µl reaction volume. A none-template control was in-
cluded in all experiments. Primer (1 µl of 10 mM) was added to the 25 µl real time PCR reaction. 
Elongation factor-1 (EF-1) and Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) mRNA were 
used as references genes because they are the product of housekeeping genes and are therefore con-
tinuously expressed to a constant amount in cells. Specific primers for the rat endothelin ETB recep-
tor, EF-1, and GAPDH receptors were designed. Table 1 presents the sequences of the specific 
genes along with the GeneBank accession ID. The real time PCR was performed with the following 
profile: 50°C for 2 minutes and 95°C for 10 minutes, followed by 40 cycles with 95°C for 15 sec-
onds and 60 °C for 1 minute.  
 
The 7500 Fast Real Time PCR sequence detection software SDS version 1.4 (Applied Biosystems, 
USA) monitors the growth of DNA in real time by optics and imaging system via the binding of a 
fluorescent dye to double-stranded DNA.  
 
2.6 Immunohistochemistry 
The middle cerebral arteries were placed into Tissue TEK (Sakura Finetek Europe B.V., Nether-
lands) and frozen. Segments were sectioned into 10-µm-thick slices and mounted on SuperFrost 
Plus slides (Menzel GMBH & COKG, Germany)  
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The primary antibodies used were sheep anti-rat ETB
 (ALX-210-506A, Alexis, USA), diluted 1:250 
and mouse anti-rat β-actin (ab11003, Abcam, USA), diluted 1:500. The endothelin ETB receptor 
and β-actin dilutions were done in PBS with 2 % donkey serum (017-000-121, Jackson ImmunoRe-
search laboratories, Inc., USA).  
The secondary antibodies used were donkey anti-sheep DL488 conjugated (713-485-003 Jackson 
ImmunoResearch laboratories, Inc., USA) diluted 1:200 and donkey anti-mouse DL549 conjugated 
(715-505-150, Jackson ImmunoResearch laboratories, Inc., USA) diluted 1:200. As control, only 
secondary antibodies were used. The antibodies were detected at the appropriate wavelength on a 
confocal microscopy (Nikon, C1plus, Nikon Instruments Inc., USA).  
 
The endothelin ETB receptor binding site could be blocked by high dose of endothelin-1 irreversi-
bly, and thereby blocked the endothelin-1 immunoreaction (De Mey et al., 2009). 
 
2.7 Calculation and statistical analyses  
Data are expressed as mean values ± standard error of the mean (S.E.M.), and n refers to the num-
ber of rats. Statistical analyses of myograph data were performed on Emax- or pEC50-values with 
one way ANOVA with Bonferroni’s test, and selected groups were compared. When analysing real 
time PCR data mRNA levels relative to the reference gene was used, and fluorescence mean inten-
sities values were analysed for the immunohistochemistry data.  
 
Groups compared in ANOVA tests: fresh middle cerebral vessel vs. 24 h organ culture with DMSO 
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and 24 h organ culture with DMSO vs. 24 h organ culture with DMSO; 24 h organ culture with 
DMSO vs. 24 h organ culture with 10 µM U0126, 0.1 µM SB202190, 1 µM SP600125, 0.1 µM 
BMS-345541, 0.01 µM IMD-0354, 0.01 µM actinomycin D, or 0.1 µM cycloheximide; 24 h organ 
culture with DSP vs. 24 h organ culture with DSP and 10 µM U0126, 0.1 µM SB202190, 1 µM 
SP600125, 0.1 µM BMS-345541, 0.01 µM IMD-0354, 0.01 µM actinomycin D, or 0.1 µM cyclo-
heximide. Statistics information given in Table 2. P< 0.05 was considered statistically significant 
(P< 0.05=*, P< 0.01=**, P< 0.001=***). 
 
2.7.1 In vitro Pharmacology 
Contractile response of each segment is expressed as percentage of the 60 mM K+ induced contrac-
tion. ETmax value represents the maximum contractile response elicited by an agonist and the 
pEC50 the negative logarithm of the drug concentration that elicited half the maximum response.  
 
2.7.2 Quantitative real time PCR  
Data were analysed with the comparative cycle threshold (CT) method (Hansen-Schwartz et al., 
2002). The CT values of EF-1 or GAPDH mRNA were used as a reference to quantify the relative 
amount of endothelin ETB receptor mRNA. The relative amount of mRNA was calculated with the 
CT values of endothelin ETB receptor mRNA in relation to the CT values of EF-1 or GAPDH 
mRNA in the sample by the formula X0/R0=2CtR-CtX, where X0 is the original amount of endothelin 
ETB receptor mRNA, R0 is the original
 amount of EF-1 or GAPDH mRNA, CtR is the CT value for 
EF-1 or GAPDH, and CTX is the CT value for the endothelin ETB receptor. Data with EF-1 as the 
reference gene is shown in results section.
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2.7.3 Immunohistochemistry 
Images were analysed by Nikon EZ-C1 software version 3.70. Fluorescence intensity was measured 
on the whole smooth muscle cell area in 3 sections; the mean of this was used. β-actin staining was 
used as reference of smooth muscle cell localization. Analysis was done by having the red 549 nm 
channel (β-actin conjugated) overlay; however, only green 488 nm channel (endothelin ETB recep-
tor conjugated) image is given for visual simplicity.  
 
3 Results 
Middle cerebral arteries were incubated for 24 h with DMSO or DSP with and without specific in-
hibitors for MEK1/2, p38, JNK, NF-κβ, transcription, and translation. The total volume of DMSO 
in the organ culture was always 2.5 µl/ml of DMEM. Carbachol (10 µM) elicited dilatation of the 5-
hydroxytryptamine (300 nM) pre-contracted middle cerebral artery segments by 50 ± 12 % in fresh 
middle cerebral vessels (n=6). After 24 h of organ culture with DMSO the dilatation by carbachol 
was 27 ± 7 % (n=8), and after 24 h the organ culture with DSP the dilatation by carbachol was 11 ± 
2 % (n=8, p< 0.05). Thus, organ culture reduced the endothelial function somewhat; addition of 
DSP to the organ culture further reduced the endothelial function. 
 
3.1 DSP concentration study 
DSP was tested in different doses; 0.05 µl – 0.40 µl DSP/ml DMEM. The K+-induced contraction, 
S6c Emax, and pEC50 values were the same for 0.05 µl and 0.15 µl DSP (data not shown).  Addi-
tion of 0.25 µl DSP/ml DMEM or a higher dose of DSP reduced the 60 mM K+-induced contrac-
tion, indicating a direct toxic effect on the vessels started to be at this DSP concentration in the or-
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gan culture. Doses of 0.30 µl or 0.40 µl DSP completely abolished the 60 mM K+-induced contrac-
tion. Therefore, we chose the DSP dose 0.15 µl henceforth. The 60 mM K+-induced contraction, 
Emax in % of 60 mM K+, and pEC50 values are given in Table 2. 
 
3.2 Potassium-induced contraction of fresh and incubated vessels 
The 60 mM K+-induced contraction (depolarisation) of the smooth muscle cells and rapid influx of 
extracellular calcium ions and was used as internal reference (Hogestatt et al., 1983). Agonist medi-
ated contractions are given in % of the 60 mM K+-induced contraction. This 60 mM K+-induced 
contraction (mN) did not differ statistically between the fresh and DMSO groups (Table 2, 60 mM 
K+-induced contraction). However the addition of 0.15 µl DSP/ml DMEM reduced the K+-induced 
contraction (Table 2, 60 mM K+-induced contraction: 24 h organ culture with 0.15 µl DSP = 1.23 ± 
0.19 mN (p< 0.05). The addition of the various blockers with DSP did not further alter the K+-
induced contraction. 
 
3.3 Endothelin ETB receptor mediated contraction 
 
The specific endothelin ETB receptor agonist sarafotoxin 6c induced a weak contraction in fresh 
middle cerebral arteries segments (5 ± 1 %). After 24 h of organ culture the endothelin ETB recep-
tor mediated contraction was enhanced significantly (103 ± 7 %; p<0.01). As shown before the or-
gan culture meditated increased of endothelin ETB receptor contraction was reduced by U0126, 
actinomycin D, and cycloheximide; demonstrating transcriptional upregulation via the MEK/ERK 
pathway (Henriksson et al., 2004;Sandhu et al., 2010). The sarafotoxin 6c induced response was 
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blocked by the specific endothelin ETB receptor inhibitor BQ788, showing that the response was 
modulated by endothelin ETB receptors. The endothelin ETB receptor mediated contraction was 
further increased significantly when DSP was added to the 24 h incubation (from 103 ± 7 % to 191 
± 14 %;p<0.05)(Fig. 1a, Table 2). The enhanced sarafotoxin 6c response was attenuated by co-
incubation with U0126 (10-5 M), SP600125 (10-6 M), actinomycin D (10-8 M), and cycloheximide 
(10-7 M) (Figures 1b, 1d, 1g, and 1h, Table 2). The sarafotoxin 6c pEC50 values were, however, 
not changed by the addition of DSP. This supports our view of attenuating in the number of the 
same receptor subtype (Adams et al., 1999;Moller et al., 1998).  
 
3.3.1 Inhibitor effect on endothelin ETB receptor mediated contraction when DMSO or DSP is 
added to the organ culture 
Once a specific inhibitor showed inhibition effect in DSP organ culture (24 h organ culture with 
0.15 µl DSP + 10-5 M U0126: Emax is reduced from 191 ± 14 % of DSP alone to 91 ± 11 % when 
U0126 is added), the effect of this specific inhibitor was tested on the organ culture method itself 
(24 h organ culture with DMSO + 10-5 M U0126: Emax is reduced from 103 ± 7 % of DMSO 
alone to 74 ± 3 % when U0126 is added). This was done to estimate on what level the inhibitor had 
an effect: organ culture mediated upregulation of endothelin ETB receptor mediated contraction or 
DSP mediated upregulation of endothelin ETB receptor mediated contraction.  
 
The DSP mediated upregulation of ETB mediated contraction (Emax = 191 ± 14 %) was reduced by 
the following inhibitors: 10-5 M U0126 (Emax = 91 ± 11 %), 10-6 M SP600125 (Emax = 126 ± 13 
%), 10-8 M actinomycin D (Emax = 22 ± 2 %), and 10-7 M cycloheximide (Emax = 114 ± 14 %). 
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SB202190, BMS-345541, and IMD-0354 failed to inhibit the DSP mediated upregulation of ETB 
mediated contraction in the concentrations tested. The inhibition effect of U0126, SP600125, actin-
omycin D, and cycloheximide were tested on vessels incubated with vehicle (DMSO). They all 
showed a tendency towards lowering the ETB mediated contraction of organ culture with DMSO 
(Emax = 103 ± 7 %), but these results were without statistical significance (Table 2). 
The pEC50 values of sarafotoxin 6c induced contraction of the vessels after organ cultured with 
DMSO or DSP, with or without the specific inhibitors were not altered. 
 
3.4 Immunohistochemistry 
Organ culture induced a strong endothelin ETB receptor mediated contraction, and this contraction 
was further enhanced by addition of DSP to the organ culture. Immunohistochemistry revealed that 
this upregulation was seen on the protein level as well. The endothelin ETB receptor protein level 
was upregulated from fresh middle cerebral artery sections to 24 h organ cultured ones. This endo-
thelin ETB receptor protein upregulation was further upregulated by addition of DSP (Figure 3b).  
Addition of U0126 (10-5 M) and cycloheximide (10-7 M) to the 24 h organ culture with DSP sig-
nificantly reduced the endothelin ETB receptor protein level, whereas SP600125 (10-6 M) and ac-
tinomycin D (10-8 M) had no effect. When the inhibitors were added to 24 h organ culture with 
DMSO, only cycloheximide gave a significant drop in endothelin ETB receptor protein level, 
whereas U0126 also lowered the endothelin ETB receptor protein level, but this was without statis-
tical significance. SP600125 and actinomycin D did not change the endothelin ETB receptor protein 
level in 24 h organ culture with DMSO. 
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3.5 Real time PCR  
Gene expression of the receptors was investigated in middle cerebral arteries by real time PCR. 
Standard curves for the respective primer pairs for ETB, EF-1, and GAPDH had almost the same 
slopes. The respective genes were therefore amplified with the same efficiency during the real time 
PCR (data not shown). None template controls were used as negative controls. Both the EF-1 and 
GAPDH reference genes gave similar results. In this article we therefore only show the mRNA lev-
els of the receptors relative to the EF-1 mRNA expression (X0/R0) (Fig. 2).  
Endothelin ETB receptor mRNA level is upregulated significantly from fresh middle cerebral arter-
ies to organ cultured for 24 h with DMSO. Addition of DSP to the 24 h organ culture incubation 24 
h did not further upregulate the endothelin ETB receptor mRNA. Addition of 10-5 M U0126, 10-6 
M SP600125, or 10-7 M cycloheximide to 24 h of organ culture with DSP shows tendency towards 
a reduction of the endothelin ETB receptor mRNA, but it was only statistical significant for 10-8 M 
actinomycin D. Only actinomycin D showed strong statistical significant downregulation of the 
endothelin ETB receptor at the mRNA level. 
 
4 Discussion 
Cigarette smoking and second-hand smoke exposure are well-known risk factors for cerebro-
vascular diseases. However, the underlying molecular mechanisms that are mediating the increased 
risk of developing cerebral vascular disease associated with smoke exposure are largely unknown.  
Here, we show that it is the lipid-soluble cigarette smoking particles, but not water-soluble cigarette 
smoke particles and nicotine per se, that induce upregulation of contractile endothelin ETB2 recep-
tors in rat cerebral arteries through activation of MAPK-mediated transcriptional mechanisms. The 
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upregulation of endothelin ETB2 receptors with enhanced contraction of cerebral arteries may lead 
to cerebral ischemia as demonstrated in previous studies in vivo (Beg et al., 2006;Stenman et al., 
2002;Wackenfors et al., 2004). Thus, targeting the MAPK-mediated molecular mechanisms may 
provide new strategies for treating cerebral diseases. 
 
Lipid-soluble cigarette smoke particles in the circulation are transported by lipoproteins to the arte-
rial wall (Shu et al., 1983), where they can directly cause damage to the arterial wall (Xu et al., 
1993;Xu et al., 2008). Increased expression of endothelin ETA receptors (Granstrom et al., 2006) 
and endothelin ETB2 receptors (Xu et al., 2008) receptors as well as thromboxane A2 (Zhang et al., 
2008) are seen, when the arteries and bronchi are exposed to lipid-soluble smoke particles at con-
centrations similar to those that occur in smokers (Benowitz et al., 1994;Foulds et al., 2003). While 
water-soluble smoke particles or nicotine at physiological levels (measured in smokers) do not have 
such effects on the receptor expression (Zhang et al., 2006). Identifying all of the toxins in cigarette 
smoke has been a challenge, as cigarette smoke contains more than 4000 different substances 
(Repace et al., 1980). Nicotine is present as an “essential reward” molecule in cigarette smoke, but 
does not mediate endothelin ETB receptor upregulation (Zhang et al., 2006). However, some effects 
of the nicotine have been observed in high non-physiological concentraction such as 0.48 and 0.96 
mg/l (Zhang et al., 2009a). Polycyclic aromatic hydrocarbons (dimethylbenzanthracene and 
benzpyren) and oxidant-like free radicals are present in the DSP preparation. These ingredients may 
cause cell proliferation and the release of vasoactive substances (Pessah-Rasmussen et al., 
1991;Stavenow et al., 1988). There are reports that suggest that endotoxin lipopolysaccharide (LPS) 
may be a group one of the toxic substances found in cigarette smoke (Larsson et al., 2004;Sebastian 
et al., 2006). LPS is a specific agonist for Toll-like receptor 4 (TLR4), and activates innate immu-
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nity and inflammation. Activation of TLR4 by LPS activates MAPK pathways (Bachar et al., 
2004), which may subsequently lead to upregulation of vascular endothelin receptors and vascular 
damage. However, this was not observed in a recent study on coronary arteries (Ghorbani et al., 
2010). The present study demonstrates for the first time in cerebral arteries that lipid-soluble ciga-
rette smoking particles, but not water-soluble cigarette smoke particle or nicotine, induces upregula-
tion of endothelin ETB2 receptors. This agrees well with previous findings obtained from studying 
the effects of cigarette smoke on rat mesenteric arteries (Xu et al., 2008;Zhang et al., 2008). 
 
The MAPKs are a group of serine/threonine kinases that are evolutionary well-conserved in all eu-
karyotes. There are three well-characterized MAPK pathways, namely MEK/ERK1/2, p38, and 
JNK (Lewis et al., 1998). Both MEK/ERK1/2 and p38 play important roles in cerebral ischemia, 
and treatment with specific inhibitors of these pathways have in experimental models of cerebral 
ischaemia revealed neuroprotection (Alessandrini et al., 1999;Barone et al., 2001;Lennmyr et al., 
2002;Namura et al., 2001;Ansar et al., 2008). In order to understand the role of MAPKs in the 
upregulation of cerebrovascular endothelin ETB receptors, we have examined the specific effects of 
different protein kinase inhibitors (Xu et al., 2008) in the organ culture model and demonstrated 
that both MEK/ERK1/2 and p38 pathways are involved in the upregulation of endothelin ETB2 
receptors (Nilsson et al., 2008). In prevous studies, U0126 and SB386023 decreased organ culture-
induced endothelin ETB receptor upregulation in rat cerebral arteries (Henriksson et al., 2004). In 
addition, immunohistochemistry revealed positive endothelin ETB receptor immunoreactivity in the 
media layer (smooth muscle cells), supporting the upregulation of the endothelin ETB receptors in 
vascular smooth muscle cells after organ culture. A crucial role of the MEK/ERK1/2 in endothelin 
ETB receptor upregulation after organ culture was demonstrated by Western blot in combination 
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with specific inhibitors (Uddman et al., 2003); this has also been seen after cerebral ischemia 
(Maddahi et al., 2008;Maddahi et al., 2009). The initiation of the upregulation is still not known but 
could be related to changes in flow or pressure (shear stress), and the subsequent activation of tyro-
sine kinase receptors or G-protein coupled receptors. Cardiovascular risk factors may induce vascu-
lar smooth muscle cell endothelin ETB receptor upregulation via activation of MAPK-mediated 
NF-κB inflammatory signal pathways (Zhang et al., 2009b). We have shown that lipid-soluble 
smoke particles can induce activation of MEK/ERK1/2, p38, and the downstream transcriptional 
factor NF-κB within 3 hrs, with a subsequent upregulation of vascular smooth muscle cell endo-
thelin ETB2 receptors after 6 hrs (Xu et al., 2008;Zheng et al., 2010). This agrees well with the 
present findings that inhibition of MEK/ERK1/2, p38, or NF-κB activities by their specific inhibi-
tors significantly attenuates the lipid-soluble smoke particles-induced upregulation of vascular 
smooth muscle cell endothelin ETB2 receptor expression in the cerebral arteries. 
 
In the present study organ culture increased endothelin ETB receptor mediated contraction, as well 
as receptor mRNA and protein levels via both transcription and translation through activation of the 
MEK/ERK pathway. Addition of lipid-soluble smoke particles to the organ culture further increases 
the endothelin ETB2 receptor-mediated contraction and protein, but with no significant effect on the 
mRNA level. This suggests a translational mechanism is in play, and supported by the fact that the 
MEK 1/2 specific inhibitor U0126 significantly inhibited this DSP-mediated elevated endothelin 
ETB receptor mediated contraction and protein level. A significant attenuation of endothelin ETB 
receptor mediated contraction and protein have been observed by the translation specific inhibitor 
cycloheximide. A decrease in lipid-soluble smoke particle-mediated elevated endothelin ETB re-
ceptor mediated contraction was observed when SP600125 and actinomycin D, but real time PCR 
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and immunohistochemistry studies could not explain this, suggesting post-translational mechanisms 
involved. The specific inhibitors used in this study were tested at the organ culture-induced increase 
in endothelin ETB receptor mediated contraction. Only U0126 deceased the endothelin ETB recep-
tor mediated contraction significantly, but this fall in contraction is not linked to transcription or 
translation. As expected actinomycin D and cycloheximide lowered the organ culture-induced in-
crease in endothelin ETB receptor mediated contraction. All in all this indicates a strong involve-
ment of MAPK signal pathways in endothelin ETB receptor expression after organ culture and this 
is further enhanced by lipid-soluble smoke particles. The role of the endothelin ETB receptor is not 
limited to contractions only, but also promote proliferation and migration of endothelial cells (Ziche 
et al., 1995).  
 
5 Conclusion 
Lipid-soluble cigarette smoking particles, but not water-soluble cigarette smoke particle or nicotine, 
induce upregulation of endothelin ETB2 receptors in rat cerebral arteries. The underlying molecular 
mechanisms that mediate upregulation of endothelin ETB2 receptors include activation of MAPK 
and transcriptional mechanisms. This may advance us understanding how cigarette smoke increases 
the risk for cerebral vascular disease, such as stroke. Understanding the molecular mechanisms be-
hind upregulation of endothelin ETB2 receptors may provide novel strategies for treatments of 
cerebral vascular diseases. 
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Figure 1 
Contractile response to the cumulative application of sarafotoxin 6c to fresh or incubated middle 
cerebral arteries with DMSO (vehicle), or DSP (a). Additional addition of specific inhibitors: 10-5 
M U0126 (b), 10-7 M SB202190 (c), 10-6 M SP600125 (d), 10-7 M BMS-345541 (e), 10-8 M 
IMD-0354 (f) 10-8 M Actinomycin D (g), or 10-7 M Cycloheximide (h). Values given represent 
means ± S.E.M. (n = 6-8). Statistical values for myograph experiments are given in Table 2. 
 
Figure 2 
Real time PCR of fresh or incubated middle cerebral arteries with DMSO (vehicle) or DSP ± 
inhibitors: 10-5 M U0126, 10-7 M SB202190, 10-8 M actinomycin D, or 10-7 M cycloheximide.  
Data are expressed as mean ± s.e.m. values relative to EF-1 mRNA levels (n= 5-7). Comparison of 
fresh vessels versus organ culture with DMSO (*** p< 0.001), organ culture with DMSO versus 
organ culture with DSP, organ culture with DMSO versus organ culture with specific inhibitors (* 
p< 0.05 for organ culture with DMSO versus organ culture with actinomycin D), or organ culture 
with DSP versus organ culture with DSP added specific inhibitors. 
 
Figure 3 
Immunohistochemistry double staining against endothelin ETB receptor and β-actin of fresh or 
incubated middle cerebral arteries with DMSO (vehicle) or DSP ± inhibitors: 10-5 M U0126, 10-7 
M SB202190, 10-8 M actinomycin D, or 10-7 M cycloheximide. Green channel (488 nm, 
endothelin ETB receptor staining) is shown, 60x magnification. Data are expressed as mean ± 
s.e.m. (n= 4-5). Statistical comparison: Fresh vessels versus organ culture with DMSO (*** P< 
0.001), and organ culture with DMSO versus organ culture with DSP (*** P< 0.001), organ culture 
Figure legends
with DMSO versus organ culture with specific inhibitors (*** P< 0.001 for organ culture DMSO 
versus organ culture with cycloheximide), and organ culture with DSP versus organ culture with 
DSP added specific inhibitors (*** P< 0.001 for organ culture with DSP versus organ culture with 
DSP added U0126 or cycloheximide). 
 
 
  
Gene GenBank accession ID Forward primer Reverse primer 
ETB  NM_017333 5'GATACGACAACTTCCGCTCCA-3' 5'-GTCCACGATGAGGACAATGAG-3' 
EF-1 NM_175838 5'-GCAAGCCCATGTGTGTTGAA-3'  5'-TGATGACACCCACAGCAACTG-3' 
GAPDH NM_017008 5′-GGCCTTCCGTGTTCCTACC-3′ 5′-CGGCATGTCAGATCCACAAC-3′ 
 
Table 1 - Primer sequences of the respective genes analysed by real time PCR 
 
Table 1
  n 60 mM K+ S6c Emax S6c pEC50 
Fresh 6 2.79 ± 0.52 5 ± 1 - 
DMSO 8 2.39 ± 0.32 103 ± 7 b 10.45 ± 0.25 
DMSO + U0126 10-5 M 6 2.36 ± 0.47 74 ± 3 9.39 ± 0.07 
DMSO + SP600125 10-6 M 6 2.51 ± 1.00 93 ± 20 10.65 ± 0.17 
DMSO + Actinomycin D 10-8 M 6 2.85 ± 0.65 73 ± 19 10.90 ± 0.22 
DMSO + Cycloheximide 10-7 M 6 2.16 ± 0.46 67 ± 9 11.18 ± 0.34 
DSP 8 1.23 ± 0.19 191 ± 14 a 10.99 ± 0.26 
DSP + U0126 10-5 M 7 0.94 ± 0.15 91 ± 11 c 10.45 ± 0.47 
DSP + SB202190 10-7 M 6 1.18 ± 0.28 198 ± 42 10.02 ± 0.54 
DSP + SP600125 10-6 M 8 1.08 ± 0.18 126 ± 13 c 10.06 ± 0.30 
DSP + BMS-345541 10-7 M 6 0.98 ± 0.22 241 ± 40 10.07 ± 0.43 
DSP + IMD-0354 10-8 M 6 0.91 ± 0.20 226 ± 27 9.40 ± 0.21 
DSP + Actinomycin D 10-8 M 8 1.77 ± 0.48 22 ± 2 c 10.42 ± 0.51 
DSP + Cycloheximide 10-7 M 6 1.18 ± 0.37 114 ± 14 b 10.98 ± 0.26 
 
Table 2 – Emax and pEC50 values of fresh or 24 h incubated middle cerebral arteries with 
DMSO or DSP ± inhibitors: MEK 1/2 inhibitor U0126, p38 inhibitor SB202190, JNK inhibitor 
SP600125, NF-κβ inhibitor BMS-345541 and IMD- 0354, transcription inhibitor Actinomycin 
D, and translation inhibitor Cycloheximide. Values given for all agonist experiments and as 
mean ± S.E.M. Statistical comparison of Emax values were performed: Fresh versus organ 
culture with DMSO, organ culture with DMSO versus organ culture with DSP, organ culture 
with DMSO versus organ culture with specific inhibitors, and organ culture with DSP versus 
organ culture with DSP added specific inhibitors (a p< 0.05, b p< 0.01, and c p< 0.001).  
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